Ovarian cancer

Open Access
MiR-575 in Exosomes of Vaginal Discharge Is Downregulated in Ovarian Cancer Patients
MAHO AZUMI, SACHIKO INUBUSHI, YOKO YANO, KENTA OBATA, KEITARO YAMANAKA and YOSHITO TERAI

Cancer Genomics & Proteomics May 2025, 22 (3) 382-396; DOI: https://doi.org/10.21873/cgp.20508
Open Access
Restoration of ARID1A Protein in ARID1A-deficient Clear Cell Carcinoma of the Ovary Attenuates Reactivity to Cytotoxic T Lymphocytes
RISA TSUNEMATSU, AIKO MURAI, YUKA MIZUE, TERUFUMI KUBO, TASUKU MARIYA, RENA MORITA, KENJI MURATA, TAKAYUKI KANASEKI, TOMOHIDE TSUKAHARA, YOSHIHIKO HIROHASHI, TSUYOSHI SAITO and TOSHIHIKO TORIGOE

Cancer Genomics & Proteomics July 2024, 21 (4) 414-420; DOI: https://doi.org/10.21873/cgp.20460
Open Access
Preoperative ctDNA Levels Are Associated With Poor Overall Survival in Patients With Ovarian Cancer
ARTURAS DOBILAS, YILUN CHEN, CHRISTIAN BRUEFFER, PIA LEANDERSSON, LAO H. SAAL and CHRISTER BORGFELDT

Cancer Genomics & Proteomics December 2023, 20 (6suppl) 763-770; DOI: https://doi.org/10.21873/cgp.20423
Open Access
Pan-cancer Analysis Reveals Cancer-dependent Expression of SOX17 and Associated Clinical Outcomes
LI XU, YOUHUANG BAI, YIHANG CHENG, XIUJIE SHENG and DEQIANG SUN

Cancer Genomics & Proteomics September 2023, 20 (5) 433-447; DOI: https://doi.org/10.21873/cgp.20395
Open Access
TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis
GWAN HEE HAN, HEE YUN, JOON-YONG CHUNG, JAE-HOON KIM and HANBYOUL CHO

Cancer Genomics & Proteomics November 2022, 19 (6) 692-702; DOI: https://doi.org/10.21873/cgp.20352
Open Access
In Vivo Effects of Conditioned Medium from Human Uterine Cervical Stem Cells in an Ovarian Cancer Xenograft Mouse Model
JUAN SENDON-LAGO, SAMUEL SEOANE, FATIMA SALEH, LUCIA GARCIA-CABALLERO, MARIA E. ARIAS, NOEMI EIRO, MANUEL MACIA, FRANCISCO J. VIZOSO, ROMAN PEREZ-FERNANDEZ and JOSE SCHNEIDER

Cancer Genomics & Proteomics September 2022, 19 (5) 570-575; DOI: https://doi.org/10.21873/cgp.20341
Open Access
In Vivo Effects of Conditioned Medium from Human Uterine Cervical Stem Cells in an Ovarian Cancer Xenograft Mouse Model
JUAN SENDON-LAGO, SAMUEL SEOANE, FATIMA SALEH, LUCIA GARCIA-CABALLERO, MARIA E. ARIAS, NOEMI EIRO, MANUEL MACIA, FRANCISCO J. VIZOSO, ROMAN PEREZ-FERNANDEZ and JOSE SCHNEIDER

Cancer Genomics & Proteomics September 2022, 19 (5) 570-575; DOI: https://doi.org/10.21873/cgp.20341
Open Access
In Vivo Effects of Conditioned Medium from Human Uterine Cervical Stem Cells in an Ovarian Cancer Xenograft Mouse Model
JUAN SENDON-LAGO, SAMUEL SEOANE, FATIMA SALEH, LUCIA GARCIA-CABALLERO, MARIA E. ARIAS, NOEMI EIRO, MANUEL MACIA, FRANCISCO J. VIZOSO, ROMAN PEREZ-FERNANDEZ and JOSE SCHNEIDER

Cancer Genomics & Proteomics September 2022, 19 (5) 570-575; DOI: https://doi.org/10.21873/cgp.20341
Open Access
In Vivo Effects of Conditioned Medium from Human Uterine Cervical Stem Cells in an Ovarian Cancer Xenograft Mouse Model
JUAN SENDON-LAGO, SAMUEL SEOANE, FATIMA SALEH, LUCIA GARCIA-CABALLERO, MARIA E. ARIAS, NOEMI EIRO, MANUEL MACIA, FRANCISCO J. VIZOSO, ROMAN PEREZ-FERNANDEZ and JOSE SCHNEIDER

Cancer Genomics & Proteomics September 2022, 19 (5) 570-575; DOI: https://doi.org/10.21873/cgp.20341
Open Access
In Vivo Effects of Conditioned Medium from Human Uterine Cervical Stem Cells in an Ovarian Cancer Xenograft Mouse Model
JUAN SENDON-LAGO, SAMUEL SEOANE, FATIMA SALEH, LUCIA GARCIA-CABALLERO, MARIA E. ARIAS, NOEMI EIRO, MANUEL MACIA, FRANCISCO J. VIZOSO, ROMAN PEREZ-FERNANDEZ and JOSE SCHNEIDER

Cancer Genomics & Proteomics September 2022, 19 (5) 570-575; DOI: https://doi.org/10.21873/cgp.20341

Main menu

User menu

Search

Ovarian cancer

Pages